Press Releases Kamada Ltd.

Equities

KMDA

IL0010941198

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 10:24:28 2024-07-08 am EDT			5-day change	1st Jan Change
2,119 ^ILa	+1.05%		+12.89%	-4.85%

Jul. 03	Stifel Initiates Kamada at Buy With $18 Price Target	MT
May. 08	Transcript : Kamada Ltd., Q1 2024 Earnings Call, May 08, 2024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kamada: Q1 Earnings Snapshot	May. 08	AQ
Kamada : Financial Highlights for the Three Months Ended March 31, 2024	May. 08	PU
Kamada Reports Strong First Quarter 2024 Financial Results with Year-Over-Year Top-Line Growth of 23% and a 96% Increase in Profitability; Raises Full-Year Financial Guidance	May. 08	AQ
Kamada to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024	May. 01	AQ
Kamada: Q4 Earnings Snapshot	Mar. 06	AQ
Kamada : Reports Fiscal Year and Fourth Quarter 2023 Financial Results, CEO letter and presentation	Mar. 06	PU
Kamada : 20F 2023 Annual Report	Mar. 06	PU
Kamada Issues 2024 CEO Letter to Shareholders	Mar. 06	AQ
Kamada Reports Strong Fiscal Year and Fourth Quarter 2023 Financial Results, and Provides Full-Year 2024 Guidance Representing Double-Digit Growth in Revenue and Profitability	Mar. 06	AQ
Kamada to Announce Fourth Quarter and Fiscal Year 2023 Financial Results, and Provide 2024 Financial Guidance on March 6, 2024	Feb. 28	AQ
Kamada : Results of Annual General Meeting of Shareholders held on December 28, 2023	Dec. 28	PU
Kamada : Other Information - Form 6-K	Dec. 28	PU
PRISM MarketView Biotech Index Top Mover Spotlight: Kamada Ltd.	Dec. 08	AQ
Kamada Announces its Largest Commercial Agreement; A Strategic Engagement with Kedrion for U.S. Distribution of KEDRAB® including $180 Million of Revenues Over First Four Years	Dec. 06	AQ
KAMADA : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K	Nov. 13	PU
Kamada: Q3 Earnings Snapshot	Nov. 13	AQ
Kamada Reports Significant Increase in Sales and Profitability in the Third Quarter and Nine Month 2023; Reiterates 2023 Revenue and Profitability Guidance	Nov. 13	AQ
Kamada to Announce Third Quarter and First Nine Months Ended September 30, 2023 Financial Results and Host Conference Call on November 13, 2023	Nov. 08	AQ
Kamada Announces Recent Achievements with CYTOGAM® including Availability of Product Manufactured by the Company for U.S Commercial Sale and Presentation of New Clinical Data	23-10-16	AQ
Kamada : Provides Corporate Update on its Israel Operations	23-10-10	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Kamada Ltd.

Equities

KMDA

IL0010941198

Press Releases

Filters